Stay updated on FLYSYN-101 Clinical Trial in MRD Positive AML
Sign up to get notified when there's something new on the FLYSYN-101 Clinical Trial in MRD Positive AML page.

Latest updates to the FLYSYN-101 Clinical Trial in MRD Positive AML page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.3.2 was added, replacing v3.3.1. No visible changes to the study page content or layout.SummaryDifference0.1%

- Check20 days agoChange DetectedAdded an editorial note that publications are provided voluntarily by the person entering information about the study and updated the revision tag to v3.3.1. The previous statement asserting that publications are about the study results was removed.SummaryDifference0.1%

- Check27 days agoChange DetectedRemoved the funding-lapse disclaimer banner from the study page, which previously warned that information may not be up to date.SummaryDifference0.4%

- Check41 days agoChange DetectedNo additions or deletions were detected in the page content.SummaryDifference0.5%

- Check70 days agoChange Detected- Added a government funding lapse notice and current operating status guidance for NIH Clinical Center, and a version bump to v3.2.0. - Removed the previous version tag v3.1.0.SummaryDifference3%

- Check77 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No changes to core content, pricing, or stock are evident.SummaryDifference0.1%

Stay in the know with updates to FLYSYN-101 Clinical Trial in MRD Positive AML
Enter your email address, and we'll notify you when there's something new on the FLYSYN-101 Clinical Trial in MRD Positive AML page.